期刊文献+

肝移植术后患者自行停药致急性排斥反应(附3例报告) 被引量:2

Analysis of acute rejection caused by immunosuppressants self-withdrawal after liver transplantation in three cases
下载PDF
导出
摘要 目的探讨肝移植术后患者自行停药致急性排斥反应(AR)的临床特点及治疗。方法回顾性分析2004年1月至2013年6月上海交通大学医学院附属瑞金医院肝移植中心收治肝移植术后因自行停药导致AR的3例患者的临床资料。结果 3例患者均因自行停止服用免疫抑制剂出现肝功能异常而入院治疗,停药18~42 d,经肝穿刺组织病理学结果明确均为急性细胞性排斥反应。给予恢复使用免疫抑制剂的同时采用肾上腺皮质激素(激素)冲击治疗或兔抗人胸腺细胞免疫球蛋白治疗后改小剂量激素维持。2例患者经治疗后好转,另1例经抢救后无效死亡。结论肝移植术后自行停药易发生AR,后果严重,应加强对患者的宣传教育,提高其服药依从性。一旦发生AR,即给予恢复使用免疫抑制剂,同时采用激素冲击或抗体治疗。 Objective To investigate the clinical features and treatment in patients with acute rejection (AR) caused by immunosuppressants self-withdrawal (IS) after liver transplantation (LT). Methods Clinical data of 3 cases with AR due to IS after LT from January 2004 to June 2013 in Liver Transplantation Center of Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University were analyzed retrospectively. Results Three patients were hospitalized for abnormal liver function after IS. The time of IS was 18- 42 d. And acute cellular rejection was confirmed by liver biopsy histopathology. Immunosuppressants were reused and small dose of hormone was used after therapy of adrenocortical hormone shock or rabbit anti-human thymocyte immunoglobulin. Two patients recovered after treatment, and 1 patient died after invalid rescue. Conclusions IS after liver transplantation is prone to AR, usually resulting in serious consequences. Publicity and education of patients should be strengthened to improve their compliance of taking medicine. Once AR occurs, immunosuppressive drugs should be reused immediately with hormone shock or antibody therapy simultaneously.
机构地区 [
出处 《器官移植》 CAS CSCD 2014年第2期100-102,122,共4页 Organ Transplantation
关键词 肝移植 急性排斥反应 免疫抑制剂 免疫耐受 Liver transplantation Acute rejection Immunosuppressant Immune tolerance
  • 相关文献

参考文献2

二级参考文献142

  • 1Marcos A,Eghtesad B,Fung JJ,Fontes P,Patel K,Devera M, et al.Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation . 2004
  • 2Battaglia M,Stabilini A,Roncarolo MG.Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood . 2005
  • 3Crispe IN,,Giannandrea M,Klein I,John B,Sampson B,Wuensch S.Cellular and molecular mechanisms of liver tolerance. Immunological Reviews . 2006
  • 4Starzl,TE,Murase,N,Abu-Elmagd,K,Gray,EA,Shapiro,R,Eghtesad,B.Tolerogenic immunosuppression for organ transplantation. The Lancet . 2003
  • 5Yoshitomi M,Koshiba T,Haga H,Li Y,Zhao X,Cheng D,et al.Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation . 2009
  • 6Martínez-Llordella,M,Puig-Pey,I,Orlando,G.Multiparameter immune profiling of operational tolerance in liver transplantation. American Journal of Transplantation . 2007
  • 7Li Y,Koshiba T,Yoshizawa A,et al.Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. American Journal of Transplantation . 2004
  • 8Takatsuki M,Uemoto S,Inomata Y,et al.Weaning of immunosuppression in living donor liver transplant recipients. Transplantation . 2001
  • 9Iwasaki A,Medzhitov R.Toll-like receptor control of the adaptive immune responses. Nature Immunology . 2004
  • 10Sawicka E,Dubois G,Jarai G,et al.The sphingosine 1-phosphate receptor agonist FTY720 differenfially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. J Immunol . 2005

共引文献8

同被引文献42

  • 1黄颖,于雪.健康教育对肾移植术后患者服药依从性的作用[J].中国组织工程研究与临床康复,2007,11(43):8773-8775. 被引量:20
  • 2Corrao G,Parodi A, Nicotra F,et al. Better compliance to antihy- pertensive medications reduces cardiovascular risk[J]. J Hyper- tens,2011,29(3) :610 - 618.
  • 3World Health Organization. Adherence to long - term therapies: evidence for action[EB/OL]. [2014 - 12 - 23]. http ://www. who. int/chronic conditions/.
  • 4Dew MA, DiMartini AF, De Vitodahhs A, et al. Rates and risk fac- tors for nonadherence to the medical regimen after adult solid or- gan transplantation[J]. Transplantation, 2007,83 : 858.
  • 5Garber MC,Nau DP,Eriekson SR,et al, The concordance of self- report with other measures of medication adherence:a summary of the literature[J]. Med Care, 2004,42 : 649.
  • 6Dobbels F,Berben L,De Geest S,et al. The psychometric proper- ties and practicability of self - report instruments to identify medi- cation nonadherence in adult transplant patients:a systematic re view[J]. Transplantation, 2010,90 : 205 - 219.
  • 7Drent G, Haagsma EB,Geest SD, et al. Prevalence of predniso- lone non- compliance in adult liver transplant recipients[J]. Transpl Int, 2005,18 : 960 - 966.
  • 8Schweizer RT,Rovelli M,Palmeri D,et al. Noncompliance in or- gan transplant recipients [ J ]. Transplantation, 1990, 49 : 374 - 377.
  • 9Germani G, Gnoato F, Borella V, et al. Non adherence to medical prescriptions in liver transplantation: a prospective longitudinal study[J]. Journal of Hepatology,2010,52 : 183 - 217.
  • 10Berlakovich GA,Langer F,Freundoreer E,et al. General eompli ance after liver transplantation for alcoholic cirrhosis[J]. Transpl Int,2000,13:129 - 135.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部